Vifor Pharma AG GNHAF:OTCPK

RT Quote | Exchange | USD
Last | 04/04/22 EDT
173.25UNCH (UNCH)
52 week range
112.75 - 183.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close173.25
  • 52 Week High183.50
  • 52 Week High Date03/18/22
  • 52 Week Low112.75
  • 52 Week Low Date11/30/21

Key Stats

  • Market Cap12,792.42M
  • Shares Out64.89M
  • 10 Day Average Volume-
  • Dividend2.04
  • Dividend Yield1.18%
  • Beta0.08
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close173.25
  • 52 Week High183.50
  • 52 Week High Date03/18/22
  • 52 Week Low112.75
  • 52 Week Low Date11/30/21
  • Market Cap12,792.42M
  • Shares Out64.89M
  • 10 Day Average Volume-
  • Dividend2.04
  • Dividend Yield1.18%
  • Beta0.08
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)2.43
  • P/E (TTM)71.25
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date04/29/2022
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its...
Jacques Theurillat
Independent Chairman of the Board of Directors
Abbas Hussain
Chief Executive Officer
Address
Rechenstrasse 37
St. Gallen
9014
Switzerland